Benefit and outcome of using temozolomide-based chemoradiotherapy followed by temozolomide alone for glioblastoma in clinical practice.

CONCLUSION: The concomitant usage of temozolomide and radiotherapy was beneficial, and statistically significant difference among groups and subgroups was observed regarding overall survival.
PMID: 29135107 [PubMed - in process]

Source: Journal of B.U.ON. - November 15, 2017 Category: Cancer & Oncology Tags: J BUON Source Type: research